+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 88
According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Irritable Bowel Syndrome (IBS). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Irritable Bowel Syndrome (IBS) market.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Key Features:
The report on Irritable Bowel Syndrome (IBS) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Irritable Bowel Syndrome (IBS) market. It may include historical data, market segmentation by Type (e.g., IBS-D Drug, IBS-C Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Irritable Bowel Syndrome (IBS) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Irritable Bowel Syndrome (IBS) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Irritable Bowel Syndrome (IBS) industry. This include advancements in Irritable Bowel Syndrome (IBS) technology, Irritable Bowel Syndrome (IBS) new entrants, Irritable Bowel Syndrome (IBS) new investment, and other innovations that are shaping the future of Irritable Bowel Syndrome (IBS).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Irritable Bowel Syndrome (IBS) market. It includes factors influencing customer ' purchasing decisions, preferences for Irritable Bowel Syndrome (IBS) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Irritable Bowel Syndrome (IBS) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Irritable Bowel Syndrome (IBS) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Irritable Bowel Syndrome (IBS) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Irritable Bowel Syndrome (IBS) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Irritable Bowel Syndrome (IBS) market.
Market Segmentation:
Irritable Bowel Syndrome (IBS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
IBS-D Drug
IBS-C Drug
Others
Segmentation by application
Women
Men
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size 2019-2030
2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Others
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
2.3.1 Irritable Bowel Syndrome (IBS) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
2.5.1 Irritable Bowel Syndrome (IBS) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
3 Irritable Bowel Syndrome (IBS) Market Size by Player
3.1 Irritable Bowel Syndrome (IBS) Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2019-2024)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) Market Size by Regions (2019-2024)
4.2 Americas Irritable Bowel Syndrome (IBS) Market Size Growth (2019-2024)
4.3 APAC Irritable Bowel Syndrome (IBS) Market Size Growth (2019-2024)
4.4 Europe Irritable Bowel Syndrome (IBS) Market Size Growth (2019-2024)
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024)
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Country (2019-2024)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Region (2019-2024)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Irritable Bowel Syndrome (IBS) Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2025-2030)
10.1.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2025-2030)
10.1.2 Americas Irritable Bowel Syndrome (IBS) Forecast
10.1.3 APAC Irritable Bowel Syndrome (IBS) Forecast
10.1.4 Europe Irritable Bowel Syndrome (IBS) Forecast
10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Forecast by Country (2025-2030)
10.2.1 United States Irritable Bowel Syndrome (IBS) Market Forecast
10.2.2 Canada Irritable Bowel Syndrome (IBS) Market Forecast
10.2.3 Mexico Irritable Bowel Syndrome (IBS) Market Forecast
10.2.4 Brazil Irritable Bowel Syndrome (IBS) Market Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Forecast by Region (2025-2030)
10.3.1 China Irritable Bowel Syndrome (IBS) Market Forecast
10.3.2 Japan Irritable Bowel Syndrome (IBS) Market Forecast
10.3.3 Korea Irritable Bowel Syndrome (IBS) Market Forecast
10.3.4 Southeast Asia Irritable Bowel Syndrome (IBS) Market Forecast
10.3.5 India Irritable Bowel Syndrome (IBS) Market Forecast
10.3.6 Australia Irritable Bowel Syndrome (IBS) Market Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Forecast by Country (2025-2030)
10.4.1 Germany Irritable Bowel Syndrome (IBS) Market Forecast
10.4.2 France Irritable Bowel Syndrome (IBS) Market Forecast
10.4.3 UK Irritable Bowel Syndrome (IBS) Market Forecast
10.4.4 Italy Irritable Bowel Syndrome (IBS) Market Forecast
10.4.5 Russia Irritable Bowel Syndrome (IBS) Market Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast by Region (2025-2030)
10.5.1 Egypt Irritable Bowel Syndrome (IBS) Market Forecast
10.5.2 South Africa Irritable Bowel Syndrome (IBS) Market Forecast
10.5.3 Israel Irritable Bowel Syndrome (IBS) Market Forecast
10.5.4 Turkey Irritable Bowel Syndrome (IBS) Market Forecast
10.5.5 GCC Countries Irritable Bowel Syndrome (IBS) Market Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Forecast by Type (2025-2030)
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bausch Health
11.1.1 Bausch Health Company Information
11.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bausch Health Main Business Overview
11.1.5 Bausch Health Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Offered
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Offered
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Main Business Overview
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Information
11.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sebela Pharmaceuticals Inc Main Business Overview
11.5.5 Sebela Pharmaceuticals Inc Latest Developments
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Information
11.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Astellas Pharmaceuticals Main Business Overview
11.6.5 Astellas Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Irritable Bowel Syndrome (IBS) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of IBS-D Drug
Table 3. Major Players of IBS-C Drug
Table 4. Major Players of Others
Table 5. Irritable Bowel Syndrome (IBS) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Table 8. Irritable Bowel Syndrome (IBS) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player (2019-2024)
Table 13. Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions (2019-2024)
Table 19. Global Irritable Bowel Syndrome (IBS) Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2019-2024)
Table 23. Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Table 25. Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Table 27. APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2019-2024)
Table 29. APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Table 31. APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2019-2024)
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Table 37. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome (IBS)
Table 46. Key Market Challenges & Risks of Irritable Bowel Syndrome (IBS)
Table 47. Key Industry Trends of Irritable Bowel Syndrome (IBS)
Table 48. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Bausch Health Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 53. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 54. Bausch Health Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Bausch Health Main Business
Table 56. Bausch Health Latest Developments
Table 57. Allergan Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 58. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 59. Allergan Main Business
Table 60. Allergan Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Allergan Latest Developments
Table 62. Takeda Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 63. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 64. Takeda Main Business
Table 65. Takeda Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Takeda Latest Developments
Table 67. Sucampo Pharmaceuticals (Mallinckrodt) Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 68. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
Table 69. Sucampo Pharmaceuticals (Mallinckrodt) Main Business
Table 70. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
Table 72. Sebela Pharmaceuticals Inc Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 73. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
Table 74. Sebela Pharmaceuticals Inc Main Business
Table 75. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sebela Pharmaceuticals Inc Latest Developments
Table 77. Astellas Pharmaceuticals Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 78. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 79. Astellas Pharmaceuticals Main Business
Table 80. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Astellas Pharmaceuticals Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Irritable Bowel Syndrome (IBS) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Irritable Bowel Syndrome (IBS) Sales Market Share by Country/Region (2023)
Figure 8. Irritable Bowel Syndrome (IBS) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2023
Figure 10. Irritable Bowel Syndrome (IBS) in Women
Figure 11. Global Irritable Bowel Syndrome (IBS) Market: Women (2019-2024) & ($ Millions)
Figure 12. Irritable Bowel Syndrome (IBS) in Men
Figure 13. Global Irritable Bowel Syndrome (IBS) Market: Men (2019-2024) & ($ Millions)
Figure 14. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2023
Figure 15. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player in 2023
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Irritable Bowel Syndrome (IBS) Market Size 2019-2024 ($ Millions)
Figure 18. APAC Irritable Bowel Syndrome (IBS) Market Size 2019-2024 ($ Millions)
Figure 19. Europe Irritable Bowel Syndrome (IBS) Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2019-2024 ($ Millions)
Figure 21. Americas Irritable Bowel Syndrome (IBS) Value Market Share by Country in 2023
Figure 22. United States Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Region in 2023
Figure 27. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2023
Figure 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2023
Figure 29. China Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country in 2023
Figure 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Figure 37. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Figure 38. Germany Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Irritable Bowel Syndrome (IBS) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 52. APAC Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 53. Europe Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 55. United States Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 56. Canada Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 59. China Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 60. Japan Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 61. Korea Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 63. India Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 64. Australia Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 67. UK Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 68. Italy Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 69. Russia Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 70. Spain Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 73. Israel Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Irritable Bowel Syndrome (IBS) Market Size 2025-2030 ($ Millions)
Figure 76. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
